The burgeoning field ofinvestigations into novel anxiolytics is rapidly expanding, with emerging research chemicals showing encouraging results in preclinical and clinical trials. These compounds often exhibit distinct mechanisms of action compared to traditional anti-anxiety medications, offering potential improvements for subjects struggling with